Dnmt3a突变限制自身反应性CD4+ Tfh应答并减轻T细胞驱动性关节炎症
该研究利用KRN+ TCR转基因过继转移自身免疫性关节炎模型,通过CRISPR-Cas9或Cd4cre介导重组引入Dnmt3a突变,评估其对自身反应性CD4+ Tfh细胞致病性的影响。结果显示,CD4+ T细胞中Dnmt3a功能缺失在免疫驱动和自身反应性激活条件下均持续降低Tfh应答与IgG产生,并使接受突变型自身反应性CD4+ T细胞的小鼠关节炎症显著减轻,伴全身白细胞介素-6和自身抗体水平下降。
要点
- CD4+ T细胞中Dnmt3a功能缺失降低Tfh应答与IgG产生
- Dnmt3a突变型自身反应性CD4+ T细胞过继转移后关节炎症显著减轻
- RA中DNMT3A突变的临床关联可能反映其他造血谱系或Tfh以外T细胞功能的作用
核心结论
- 野生型Dnmt3a在免疫驱动和自身反应性条件下均支持Tfh应答。
- CD4+ T细胞中Dnmt3a功能缺失限制自身反应性炎症,提示RA中的临床关联可能反映其他造血谱系或Tfh依赖性应答以外的T细胞功能效应。
研究设计与样本
- 采用KRN+ TCR转基因过继转移自身免疫性关节炎模型,其中自身反应性CD4+ Tfh细胞驱动疾病。
- 通过CRISPR-Cas9或Cd4cre介导重组引入Dnmt3a突变,并使用竞争性骨髓嵌合体、绵羊红细胞免疫和自身反应性T细胞转移评估Tfh应答、抗体产生与关节炎症。
主要发现
- CD4+ T细胞中DNMT3A功能缺失在免疫驱动和自身反应性激活中均持续降低Tfh应答与IgG产生。
- 在KRN+转移模型中,接受Dnmt3a突变型自身反应性CD4+ T细胞的小鼠关节炎症显著减轻,伴全身白细胞介素-6和自身抗体水平降低。
临床怎么用
- 该结果为解释RA中DNMT3A克隆性造血与血清阳性疾病及炎症标志物升高的关联提供机制线索,提示该关联未必由CD4+ Tfh细胞致病性增强介导。
局限性
- 研究基于KRN+ TCR转基因过继转移小鼠模型,结论向人类RA的外推需谨慎。
- DNMT3A突变由CRISPR-Cas9或Cd4cre介导重组引入,与患者体细胞突变的具体类型和克隆背景可能不同。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Somatic DNMT3A mutations are the most common drivers of clonal hematopoiesis in patients with rheumatoid arthritis (RA) and have been associated with seropositive disease and increased markers of inflammation. These mutations are predominantly hypomorphic or dominant-negative, reducing DNMT3A function. We tested whether Dnmt3a mutations enhance the pathogenicity of autoreactive CD4+ T cells. METHODS: Using the KRN+ TCR transgenic transfer model of autoimmune arthritis, in which autoreactive CD4+ T follicular helper (Tfh) cells drive disease, we assessed the impact of Dnmt3a mutations introduced by CRISPR-Cas9 or Cd4cre-mediated recombination. Competitive bone marrow chimeras, immunization with sheep red blood cells, and autoreactive T cell transfer were used to evaluate Tfh responses, antibody production, and joint inflammation. RESULTS: Loss of DNMT3A function in CD4+ T cells consistently reduced Tfh responses and IgG production during both immunization-driven and autoreactive activation. In the KRN+ transfer model, mice receiving Dnmt3a-mutant autoreactive CD4+ T cells developed significantly attenuated joint inflammation, accompanied by reduced systemic interleukin-6 and autoantibody levels. CONCLUSION: Wild-type Dnmt3a supports Tfh responses under both immunization-driven and autoreactive conditions. Dnmt3a loss-of-function in CD4+ T cells limits autoreactive inflammation, suggesting that clinical associations in RA may reflect effects in other hematopoietic lineages or T cell functions beyond Tfh-dependent responses.
引用
- Shen Y, Boddul S, Li Z, et al. Dnmt3a Mutations Limit Normal and Autoreactive CD4+ T Follicular Helper Responses and Attenuate T Cell-Driven Joint Inflammation. Arthritis Rheumatol. 2026. PMID: 42373566. doi:10.1002/art.70267
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。